Clinical significance of low-grade renal artery stenosis

Journal of Internal Medicine

Volumn 267, Issue 3, 2010, Pages 305-315

  Dechering, D G ^a,b   Kruis, H M E ^a   Adiyaman, A ^a   Thien, Th ^a   Postma, C T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Atherosclerosis; Cardiovascular clinical research; Cardiovascular risk factors; Hypertension; Renal disease

Indexed keywords

ADULT; ANGINA PECTORIS; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; PRIORITY JOURNAL; PROTEINURIA;

ADULT; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL ARTERY OBSTRUCTION; RISK FACTORS;

EID: 75749142265     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02144.x     Document Type: Article

References (30)

1. Conlon PJ, Athirakul K, Kovalik E et al. Survival in renal vascular disease. J Am Soc Nephrol 1998 9 : 252 256.
2. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001 344 : 431 442.
3. Hanovici H, Zinicda N. Experimental renal artery stenosis. Diagnostic significance of arterial haemodynamics. J Cardiovasc Surg 1962 3 : 259 262.
4. Rundback JH, Sacks D, Kent KC et al. Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation 2002 106 : 1572 1585. (Pubitemid 35050888)
5. de Bruyne B, Manoharan G, Pijls NH et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol 2006 48 : 1851 1855.
6. Tollefson DF, Ernst CB. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg 1991 14 : 327 331.
7. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE Jr. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg 1994 19 : 250 257.
8. Basta LL, Williams C, Kioschos JM, Spector AA. Regression of atherosclerotic stenosing lesions of the renal arteries and spontaneous cure of systemic hypertension through control of hyperlipidemia. Am J Med 1976 61 : 420 423.
9. Khong TK, Missouris CG, Belli AM, MacGregor GA. Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy. J Hum Hypertens 2001 15 : 431 433.
10. Fava C, Minuz P, Patrignani P, Morganti A. Renal artery stenosis and accelerated atherosclerosis: which comes first? J Hypertens 2006 24 : 1687 1696.
11. Vasbinder GB, Nelemans PJ, Kessels AG et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004 141 : 674 682.
12. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003 21 : 1011 1053.
13. Beaubien ER, Card CM, Card SE, Biem HJ, Wilson TW. Accuracy of the Dinamap 1846 XT automated blood pressure monitor. J Hum Hypertens 2002 16 : 647 652.
14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
15. Krijnen P, van Jaarsveld BC, Steyerberg EW, Man in 't Veld AJ, Schalekamp MA, Habbema JD. A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998 129 : 705 711.
16. Wright JR, Shurrab AE, Cheung C et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis 2002 39 : 1153 1161.
17. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 2001 60 : 1490 1497.
18. Crowley JJ, Santos RM, Peter RH et al. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 1998 136 : 913 918.
19. Gibson CM, Pinto DS, Murphy SA et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 2003 42 : 1535 1543.
20. Knight EL, Rimm EB, Pai JK et al. Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol 2004 15 : 1897 1903.
21. Cheung CM, Wright JR, Shurrab AE et al. Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol 2002 13 : 149 157.
22. Myers DI, Poole LJ, Imam K, Scheel PJ, Eustace JA. Renal artery stenosis by three-dimensional magnetic resonance angiography in type 2 diabetics with uncontrolled hypertension and chronic renal insufficiency: prevalence and effect on renal function. Am J Kidney Dis 2003 41 : 351 359.
23. Epstein FH. Oxygen and renal metabolism. Kidney Int 1997 51 : 381 385.
24. Levin A, Linas S, Luft FC, Chapman AB, Textor S. Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension. Am J Nephrol 2007 27 : 212 220.
25. Stamler J, Stamler R, Neaton JD et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999 282 : 2012 2018.
26. Xxxxx XX Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Circulation 2002 106 : 3141 3373.
27. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the framingham heart study: a cohort study. Lancet 2001 358 : 1682 1686.
28. Graham I, Atar D, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007 14 (Suppl. 2 S1 113.
29. Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004 110 : 227 239.
30. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 324 : 71 86.